{"nct_id":"NCT02551874","title":"A 24-week Open-Label, Phase 3b Trial With a 28-week Extension to Evaluate the Efficacy and Safety of Saxagliptin Co-administered With Dapagliflozin Compared to Insulin Glargine in Subjects withType 2 Diabetes Who Have Glycemic Control on Metformin","status":"COMPLETED","status_verified_date":"2018-11","start_date":"2015-10-20","start_date_type":"ACTUAL","primary_completion_date":"2017-05-08","primary_completion_date_type":"ACTUAL","completion_date":"2017-11-10","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["AZN"]}